NCT00556504View on ClinicalTrials.gov

The Effects of Adding TCM-700C on the Standard Combination Treatment for Patients With Genotype 1 Hepatitis C Infection

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

January 31, 2011

Study Completion Date

May 31, 2011

Conditions

Chronic Hepatitis C

Interventions

DRUG

TCM-700C

An add-on drug to conventional treatment of Hepatitis C

DRUG

Peginterferon alfa-2a

conventional treatment of Hepatitis C

DRUG

Ribavirin

conventional treatment of Hepatitis C

DRUG

Placebo

Placebo, without acting ingredient.

Trial Locations (1)

333

Chang Gung Memorial Hospital, Taoyuan District

All Listed Sponsors

lead

TCM Biotech International Corp.

INDUSTRY

NCT00556504 - The Effects of Adding TCM-700C on the Standard Combination Treatment for Patients With Genotype 1 Hepatitis C Infection | Biotech Hunter | Biotech Hunter